DNA versus RNA oxidation in Parkinson’s disease: Which is more important?

Aarsland, 2010, The epidemiology of dementia associated with Parkinson's disease, J. Neurol. Sci., 289, 18, 10.1016/j.jns.2009.08.034 Abe, 2003, Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease, Neurosci. Lett., 336, 105, 10.1016/S0304-3940(02)01259-4 Alam, 1997, Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra, J. Neurochem., 69, 1196, 10.1046/j.1471-4159.1997.69031196.x Bharath, 2002, Glutathione, iron and Parkinson's disease, Biochem. Pharmacol., 64, 1037, 10.1016/S0006-2952(02)01174-7 Blin, 1994, Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy, J. Neurol. Sci., 125, 95, 10.1016/0022-510X(94)90248-8 Bloomer, 2008, Blood oxidative stress biomarkers: influence of sex, excercise training status and dietary intake, Gend Med., 5, 218, 10.1016/j.genm.2008.07.002 Borkum, 2016, Migraine triggers and oxidative stress: a narrative review and synthesis, Headache, 56, 12, 10.1111/head.12725 Braak, 2006, Cognitive decline correlates with neuropathologic stage in Parkinson's diseae, J. Neurol. Sci., 248, 255, 10.1016/j.jns.2006.05.011 Cabezas, 2014, Astrocytic modulation of blood brain barrier: perspectives on Parkinson's disease, Front. Cell. Neurosci., 8, 211, 10.3389/fncel.2014.00211 Chen, 2009, Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease, Neurobiol. Dis., 33, 429, 10.1016/j.nbd.2008.11.011 Compta, 2011, Lewy-and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?, Brain, 134, 1493, 10.1093/brain/awr031 Dryanovski, 2013, Calcium entry and alpha-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons, J. Neurosci. Off. J. Soc. Neurosci., 33, 10154, 10.1523/JNEUROSCI.5311-12.2013 Emre, 2007, Clinical diagnostic criteria for dementia associated with Parkinson's disease, Mov. Disord., 22, 1689, 10.1002/mds.21507 Gmitterova, 2009, 8-OHdG in cerebrospinal fluid as a marker of oxidative stress in various neurodegenerative diseases, Neurodegener. Dis., 6, 263, 10.1159/000237221 Hall, 2014, Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease, Brain, 137, 2493, 10.1093/brain/awu193 Hofer, 2006, A method to determine RNA and DNA oxidation simultaneously by HPLC-ECD: greater RNA than DNA oxidation in rat liver after doxorubicin administration, Biol. Chem., 387, 103, 10.1515/BC.2006.014 Irwin, 2012, Neuropathologic substrates of Parkinson disease dementia, Ann. Neurol., 72, 587, 10.1002/ana.23659 Isobe, 2010, Neurosci. Lett., 469, 159, 10.1016/j.neulet.2009.11.065 Jenner, 1998, Oxidative mechanisms in nigral cell death in Parkinsońs disease, Mov. Disord., 13, 24 Jobert, 2014, Regulatory mechanisms of RNA function: emerging roles of DNA repair enzymes, Cell. Mol. Life Sci. CMLS, 71, 2451, 10.1007/s00018-014-1562-y Kempster, 2010, Relationships between age and late progression of Parkinson's disease: a clinico-pathological study, Brain, 133, 1755, 10.1093/brain/awq059 Kikuchi, 2002, Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy, Neurobiol. Dis., 9, 244, 10.1006/nbdi.2002.0466 Li, 2015, Vascular risk factors aggravate the progression of Parkinson's disease: a five-year follow-up study in Chinese patients, International journal of, Clin. Exp. Med., 8, 9897 Lin, 2006, Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases, Nature, 443, 787, 10.1038/nature05292 Martinet, 2004, Reactive oxygen species induce RNA damage in human atherosclerosis, Eur. J. Clin. Invest., 34, 10.1111/j.1365-2362.2004.01343.x McKeith, 2006, Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop, J. Alzheimers Dis., 9, 417, 10.3233/JAD-2006-9S347 Mecocci, 1993, Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain, Ann. Neurol., 34, 609, 10.1002/ana.410340416 Morris, 2017, Nitrosative stress, hypernitrosylation, and autoimmune responses to nitrosylated proteins: new pathways in neuroprogressive disorders including depression and chronic fatigue syndrome, Mol. Neurobiol., 54, 4271, 10.1007/s12035-016-9975-2 Nunomura, 2002, Neuronal RNA oxidation is a prominent feature of dementia with Lewy bodies, Neuroreport, 13, 2035, 10.1097/00001756-200211150-00009 Nunomura, 2009, RNA oxidation in Alzheimer's disease and related neurodegenerative disorders, Acta Neuropathol., 118, 151, 10.1007/s00401-009-0508-1 Nunomura, 2012, The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons, J. Neuropathol. Exp. Neurol., 71, 233, 10.1097/NEN.0b013e318248e614 Olanow, 2015, Levodopa effects on cell death and the natural history of Parkinson's disease, Mov. Disord., 30, 37, 10.1002/mds.26119 Pan, 2013, Gray matter atrophy in Parkinson's disease with dementia: evidence from meta-analysis of voxel-based morphometry studies, Neurol. Sci., 34, 613, 10.1007/s10072-012-1250-3 Peoples, 2005, Recent developments in analytical methodology for 8-hydroxy-2-deoxyguanosine and related products, J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 827, 5, 10.1016/j.jchromb.2005.10.001 Sabbagh, 2009, Parkinson disease with dementia, Comparing Patients Without Alzheimer Pathol. Alzheimer Dis. Assoc. Disord., 23, 295, 10.1097/WAD.0b013e31819c5ef4 Sanders, 2014, Mitochondrial DNA damage: molecular markers of vulnerable nigral neurons in Parkinson's disease, Neurobiol. Dis., 70, 214, 10.1016/j.nbd.2014.06.014 Sato, 2005, Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease, Neurology, 64, 1081, 10.1212/01.WNL.0000154597.24838.6B Shan, 2007, Messenger RNA oxidation is an early event preceding cell death and causes reduced protein expression, FASEB J., 21, 2753, 10.1096/fj.07-8200com Subramaniam, 2013, Mitochondrial dysfunction and oxidative stress in Parkinson's disease, Prog. Neurobiol., 106-107, 17, 10.1016/j.pneurobio.2013.04.004 Tansey, 2007, Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention, Exp. Neurol., 208, 1, 10.1016/j.expneurol.2007.07.004 Teunissen, 2009, A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking, Neurology, 73, 1914, 10.1212/WNL.0b013e3181c47cc2 Yu, 2013, Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans, Circulation, 128, 702, 10.1161/CIRCULATIONAHA.113.002271 Zhang, 1999, Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons, Am. J. Pathol., 154, 1423, 10.1016/S0002-9440(10)65396-5 Zucca, 2017, Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease, Prog. Neurobiol., 155, 96, 10.1016/j.pneurobio.2015.09.012